Valdecoxib是一种强有效和选择性的COX-2抑制剂,IC50为5nM.
Valdecoxib is a potent and selective inhibitor of COX-2 with IC50 of 5 nM.
10.2mg/kg 口服
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Talley JJ, et al. J Med Chem, 2000, 43(5), 775-777.
[2] Roumie, Christianne L. Stroke (2008), 39(7), 2037-2045.
[3] Gierse JK, et al. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity. J Pharmacol Exp Ther. 2005 Mar;312(3):1206-12.
分子式 C16H14N2O3S |
分子量 314.36 |
CAS号 181695-72-7 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 63 mg/mL |
Water <1 mg/mL |
Ethanol 18 mg/mL |
体内溶解度
NCT00650455 | Arthritis, Rheumatoid | Drug: valdecoxib|Drug: naproxen|Drug: placebo | Pfizer | Phase 4 | 2003-02-01 | 2008-07-18 |
NCT00419549 | ERCP|Pancreatitis | Drug: Glyceryl - trinitrate|Drug: Valdecoxib | All India Institute of Medical Sciences, New Delhi | Phase 2|Phase 3 | 2003-10-01 | 2009-01-28 |
NCT00021996 | Pain|Unspecified Adult Solid Tumor, Protocol Specific | Drug: valdecoxib | Dana-Farber Cancer Institute|National Cancer Institute (NCI) | 2001-01-01 | 2013-07-17 | |
NCT00660855 | Pain, Post Surgical | Drug: parecoxib/valdecoxib | Pfizer | Phase 4 | 2004-06-01 | 2008-04-21 |
NCT00649610 | Low Back Pain | Drug: valdecoxib|Drug: diclofenac | Pfizer | Phase 4 | 2002-11-01 | 2008-04-07 |
NCT00260325 | Pain|Hyperalgesia | Drug: valdecoxib | Penn State University|Pfizer|National Institutes of Health (NIH) | Phase 4 | 2004-08-01 | 2007-05-29 |
NCT00652808 | Osteoarthritis|Knee | Drug: valdecoxib|Drug: naproxen | Pfizer | Phase 3 | 2004-05-01 | 2008-04-07 |
NCT00671320 | Pain|Sprains and Strains|Sprain | Drug: valdecoxib|Drug: diclofenac | Pfizer | Phase 4 | 2002-12-01 | 2008-04-30 |
NCT00683137 | Pain|Hallux Valgus | Drug: valdecoxib|Drug: valdecoxib|Drug: valdecoxib/placebo | Pfizer | Phase 3 | 2002-10-01 | 2008-05-22 |
NCT00661635 | Laparoscopic Cholecystectomy|Pain | Drug: placebo|Drug: valdecoxib|Drug: valdecoxib | Pfizer | Phase 3 | 2002-11-01 | 2008-04-21 |
NCT00657449 | Acute Pain | Drug: valdecoxib|Drug: rofecoxib | Pfizer | Phase 4 | 2003-06-01 | 2008-04-08 |
NCT00653354 | Pain, Post-Surgical | Drug: valdecoxib|Drug: valdecoxib/placebo|Drug: placebo | Pfizer | Phase 3 | 2002-12-01 | 2008-04-07 |
NCT00648258 | Osteoarthritis | Drug: valdecoxib|Drug: naproxen | Pfizer | Phase 3 | 2003-07-01 | 2008-04-07 |
NCT00647829 | Pharyngitis | Drug: valdecoxib|Drug: valdecoxib|Drug: placebo | Pfizer | Phase 3 | 2003-02-01 | 2008-04-23 |
NCT00649415 | Dysmenorrhea | Drug: piroxicam|Drug: valdecoxib | Pfizer | Phase 4 | 2003-01-01 | 2008-04-07 |
NCT00650039 | Pain | Drug: placebo|Drug: valdecoxib|Drug: valdecoxib | Pfizer | Phase 3 | 2004-03-01 | 2008-06-03 |
NCT00650598 | Pain, Postoperative | Drug: valdecoxib|Drug: diclofenac | Pfizer | Phase 4 | 2004-03-01 | 2008-10-06 |
NCT00650624 | Osteoarthritis, Knee | Drug: valdecoxib|Drug: valdecoxib|Drug: valdecoxib|Drug: placebo | Pfizer | Phase 2 | 2003-06-01 | 2008-04-07 |
NCT00636064 | Pain | Drug: Parecoxib Sodium/Valdecoxib|Drug: Placebo/Valdecoxib|Other: Placebo/Placebo | Pfizer | Phase 3 | 2003-01-01 | 2008-10-09 |
NCT00122096 | Neurosurgery|Pain | Drug: valdecoxib | University of Washington|Pfizer | Phase 4 | 2002-11-01 | 2008-09-25 |
NCT00651300 | Pain | Drug: Parecoxib/Valdecoxib|Drug: Placebo | Pfizer | Phase 3 | 2003-04-01 | 2009-06-08 |
NCT00092300 | Postoperative Pain | Drug: MK0966, rofecoxib|Drug: Comparator: valdecoxib | Merck Sharp & Dohme Corp. | Phase 3 | 2002-05-01 | 2015-07-31 |
NCT00092339 | Postoperative Pain | Drug: MK0966, rofecoxib|Drug: Comparator: valdecoxib, placebo | Merck Sharp & Dohme Corp. | Phase 3 | 2002-08-01 | 2015-09-15 |
NCT01541137 | Postoperative Pain | Drug: Diclofenac|Drug: parecoxib/ valdecoxib|Device: patient controlled epidural analgesia | Helsinki University Central Hospital|Academy of Finland | 2004-03-01 | 2012-02-28 | |
NCT01361789 | Rupture of Anterior Cruciate Ligament | Drug: parecoxib, valdecoxib, etoricoxib|Drug: Dexamethasone|Drug: parecoxib, valdecoxib, parecoxib and dexamethasone | Asker & Baerum Hospital | Phase 4 | 2004-01-01 | 2011-05-26 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们